Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploiting the EBV-MS Link to Quell Secondary Progressive Disease
Pathological Anatomy: Illustrations of the elementary forms of disease.
Multiple Sklerose und Erbanlage
Guthy-Jackson Charitable Foundation
Postdoctoral position in research on myelination
Fuel Injection
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Stem Cells Stop the Train of MS Damage in Mice
MS Research Roundup: July 9, 2014
MS Research Roundup: March 31, 2014
Peripheral B Cell Activation May Drive CNS Autoimmunity in MS
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
MS Genetics: The Outer Limits
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
Multiple Sclerosis Trust
MS Trial Alert
National MS Society: Career Transition Fellowships
Papers: 13 Jun 2014 - 20 Jun 2014
FDA Approves Alemtuzumab for MS
National Institutes of Health
NMSS Barancik Prize for Innovation in MS Research: Call for Nominations
Papers: 30 May 2014 - 6 Jun 2014
MS Research Australia
Gray matter atrophy is related to long-term disability in multiple sclerosis.
Conducting Neural Dissonance
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »